Literature DB >> 9063242

Visual impairment in Australia: distance visual acuity, near vision, and visual field findings of the Melbourne Visual Impairment Project.

H R Taylor1, P M Livingston, Y L Stanislavsky, C A McCarty.   

Abstract

PURPOSE: To describe the age-specific and gender-specific rates of blindness and visual impairment in urban adults aged 40 years and older.
METHODS: A population-based sample of residents was recruited. Presenting and best-corrected distance visual acuities were assessed. Functional near vision was measured at each participant's preferred distance. Visual field examination was performed with a Humphrey Field Analyzer (HFA); those unable to perform the field analyzer test attempted a Bjerrum screen or confrontation field.
RESULTS: The study population comprised 3,271 residents (83% of eligible) from ages 40 to 98 years; 54% were women. Overall, 56% of the study population wore distance correction; this was significantly lower in men but higher in the older age groups. Age-adjusted rates of blindness were 0.066% in men and 0.170% in women. Vision with current correction improved after refraction by gender and age. Direct age-standardized rates of functional near vision did not vary significantly by gender. Forty-six people had significant visual field loss in their better eye. The proportion of participants with constriction of the visual field to within 20 degrees of fixation was similar for men and women when controlled for age (odds ratio, 0.81; 95% confidence interval, 0.44 to 1.49) but increased significantly with age controlled for gender. Visual field abnormalities were detected in 548 right eyes (17%) and 533 left eyes (16%).
CONCLUSIONS: Although overall rates of blindness because of visual acuity loss were relatively low, nearly three times more people had visual impairment because of visual field loss than visual acuity loss. These results highlight the need to target blindness prevention programs to the aging population, with a special emphasis on women.

Entities:  

Mesh:

Year:  1997        PMID: 9063242     DOI: 10.1016/s0002-9394(14)70128-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  46 in total

1.  Visual acuity measurements in a national sample of British elderly people.

Authors:  J C van der Pols; C J Bates; P V McGraw; J R Thompson; M Reacher; A Prentice; S Finch
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Visual acuity in northern China in an urban and rural population: the Beijing Eye Study.

Authors:  L Xu; J Li; T Cui; A Hu; Y Zheng; Y Li; B Sun; B Ma; J B Jonas
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  Visual impairment in the 40- to 64-year-old population of Shahroud, Iran.

Authors:  H Hashemi; M Khabazkhoob; M H Emamian; M Shariati; A Fotouhi
Journal:  Eye (Lond)       Date:  2012-05-18       Impact factor: 3.775

4.  Uncorrected refractive error: the major and most easily avoidable cause of vision loss.

Authors: 
Journal:  Community Eye Health       Date:  2007-09

5.  Uncorrected refractive error and presbyopia: accommodating the unmet need.

Authors:  Rupert R A Bourne
Journal:  Br J Ophthalmol       Date:  2007-07       Impact factor: 4.638

6.  Uncorrected refractive errors and spectacle utilisation rate in Tehran: the unmet need.

Authors:  A Fotouhi; H Hashemi; B Raissi; K Mohammad
Journal:  Br J Ophthalmol       Date:  2006-02-17       Impact factor: 4.638

7.  The challenge of providing spectacles in the developing world.

Authors:  B A Holden; S Sulaiman; K Knox
Journal:  Community Eye Health       Date:  2000

8.  The role of optometry in vision 2020.

Authors: 
Journal:  Community Eye Health       Date:  2002

9.  Prevalence of visual impairment, blindness, and cataract surgery in the Hong Kong elderly.

Authors:  John J Michon; Joseph Lau; Wing Shing Chan; Leon B Ellwein
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

10.  Vision impairment and older drivers: who's driving?

Authors:  J E Keeffe; C F Jin; L M Weih; C A McCarty; H R Taylor
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.